[1]
2025. COMPARISON OF SGLT2 INHIBITORS AND DPP4 INHIBITORS IN DIABETIC PATIENTS WITH HEART FAILURE. The Research of Medical Science Review. 3, 7 (Jul. 2025), 2055–2066.